Tabibian, James H.

Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis - a pilot study

Tabibian, J. H., Weeding, E., Jorgensen, R. A., Petz, J. L., Keach, J. C., Talwalkar, J. A., & Lindor, K. D. (2013) · Alimentary Pharmacology & Therapeutics

Liver Diseases and ImmunityInflammatory Bowel Disease

Cited by 267

Cholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitis

Tabibian, J. H., O'Hara, S. P., Splinter, P. L., Trussoni, C. E., & LaRusso, N. F. (2014) · Hepatology

Liver Diseases and ImmunityTelomeres, Telomerase, and Senescence

Cited by 241

Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis

Tabibian, J. H., O'Hara, S. P., Trussoni, C. E., Tietz, P. S., Splinter, P. L., Mounajjed, T., Hagey, L. R., & LaRusso, N. F. (2016) · Hepatology

Liver Diseases and ImmunityGut microbiota and health

Cited by 223

Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis

Ali, A. H., Tabibian, J. H., Nasser‐Ghodsi, N., Lennon, R. J., DeLeon, T., Borad, M. J., Hilscher, M., Silveira, M. G., Carey, E. J., & Lindor, K. D. (2018) · Hepatology

Liver Diseases and ImmunityCholangiocarcinoma and Gallbladder Cancer Studies

Cited by 140

Role of the Microbiota and Antibiotics in Primary Sclerosing Cholangitis

Tabibian, J. H., Talwalkar, J. A., & Lindor, K. D. (2013) · BioMed Research International

Liver Diseases and ImmunityGut microbiota and health

Cited by 91

Predictors of health-related quality of life and adherence in Crohn's disease and ulcerative colitis: implications for clinical management

Tabibian, A., Tabibian, J. H., Beckman, L. J., Raffals, L. L., Papadakis, K. A., & Kane, S. V. (2015) · Digestive Diseases and Sciences

Inflammatory Bowel DiseaseMedication Adherence and Compliance

Cited by 89

Physiology of Cholangiocytes

Tabibian, J. H., Masyuk, A. I., Masyuk, T. V., O'Hara, S. P., & LaRusso, N. F. (2013) · Comprehensive Physiology

Drug Transport and Resistance MechanismsLiver physiology and pathology

Cited by 52

Ursodeoxycholic acid in primary sclerosing cholangitis: if withdrawal is bad, then administration is good (right?)

Tabibian, J. H., & Lindor, K. D. (2014) · Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 42

Complications, symptoms, quality of life and pregnancy in cholestatic liver disease

Zakharia, K., Tabibian, A., Lindor, K. D., & Tabibian, J. H. (2018) · Liver International

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 42